ClearAlpha Technologies’s Abbott ABT Stock Holding History

ClearAlpha Technologies’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$418K	Buy	+4,069	New	+$459K	0.86%	43

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearAlpha Technologies's ABT Position: Q1 2026 in Review

ClearAlpha Technologies opened a new position in Abbott (ABT) in Q1 2026: 4,069 shares worth $418K. The stake represents 0.86% of the portfolio and ranks #43 among its holdings.

3,084 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

ClearAlpha Technologies held 4,069 shares of Abbott worth $418K as of Q1 2026.
Abbott was a new ClearAlpha Technologies position in Q1 2026.
Abbott made up 0.86% of ClearAlpha Technologies's portfolio in Q1 2026, its #43 holding.
3,084 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on ClearAlpha Technologies's 13F filing for Q1 2026, filed 15 May 2026.